XML 22 R7.htm IDEA: XBRL DOCUMENT v3.8.0.1
Consolidated Statements of Equity - USD ($)
shares in Thousands, $ in Thousands
Total
Contingently Redeemable Noncontrolling Interest
Common Stock Shares
Additional Paid-in Capital
Retained Earnings
Accumulated Other Comprehensive Income (Loss)
Total Attributable to Greenbrier
Attributable to Noncontrolling Interest
Equity Excluding Contingently Redeemable Noncontrolling Interest [Member]
2024 Convertible Senior Notes
Additional Paid-in Capital
2024 Convertible Senior Notes
Total Attributable to Greenbrier
2024 Convertible Senior Notes
Equity Excluding Contingently Redeemable Noncontrolling Interest [Member]
2024 Convertible Senior Notes Issuance Costs
Additional Paid-in Capital
2024 Convertible Senior Notes Issuance Costs
Total Attributable to Greenbrier
2024 Convertible Senior Notes Issuance Costs
Equity Excluding Contingently Redeemable Noncontrolling Interest [Member]
Beginning balance (in shares) at Aug. 31, 2014     27,364                        
Beginning balance at Aug. 31, 2014       $ 235,763 $ 282,559 $ (6,932) $ 511,390 $ 62,331 $ 573,721            
Net earnings $ 265,309       192,832   192,832 72,477 265,309            
Other comprehensive income (loss), net (14,429)         (14,273) (14,273) (156) (14,429)            
Noncontrolling interest adjustments               17,215 17,215            
Purchase of noncontrolling interest               (80) (80)            
Joint venture partner distribution declared               (21,136) (21,136)            
Restricted stock awards (net of cancellations) (in shares)     (15)                        
Restricted stock awards (net of cancellations)       22,622     22,622   22,622            
Unamortized restricted stock       (24,477)     (24,477)   (24,477)            
Restricted stock amortization       19,459     19,459   19,459            
Excess tax benefit from restricted stock awards       2,908     2,908   2,908            
Conversion of convertible notes, net of debt issuance costs (in shares)     2,945                        
Conversion of convertible notes, net of debt issuance costs       109,387     109,387   109,387            
Dividends         (16,792)   (16,792)   (16,792)            
Repurchase of stock       (70,218)     (70,218)   (70,218)            
Repurchase of stock, shares     (1,387)                        
Ending Balance (in shares) at Aug. 31, 2015     28,907                        
Ending Balance at Aug. 31, 2015       295,444 458,599 (21,205) 732,838 130,651 863,489            
Ending Balance at Aug. 31, 2016   $ (2,140)                          
Net earnings 284,824       183,213   183,213 101,611 284,824            
Other comprehensive income (loss), net $ (5,586)         (5,548) (5,548) (38) (5,586)            
Noncontrolling interest adjustments               526 526            
Purchase of noncontrolling interest               (1,195) (1,195)            
Joint venture partner distribution declared               (94,439) (94,439)            
Investment by joint venture partner               5,400 5,400            
Restricted stock awards (net of cancellations) (in shares)     353                        
Restricted stock awards (net of cancellations)       6,055     6,055   6,055            
Unamortized restricted stock       (11,555)     (11,555)   (11,555)            
Restricted stock amortization       22,502     22,502   22,502            
Excess tax benefit from restricted stock awards       2,813     2,813   2,813            
Dividends         (23,634)   (23,634)   (23,634)            
Repurchase of stock       (32,373)     (32,373)   (32,373)            
Repurchase of stock, shares     (1,055)                        
Ending Balance (in shares) at Aug. 31, 2016 28,205   28,205                        
Ending Balance at Aug. 31, 2016 $ 1,016,827     282,886 618,178 (26,753) 874,311 142,516 1,016,827            
Contingently redeemable noncontrolling interest   38,288                          
Ending Balance at Aug. 31, 2017   $ 36,148                          
Net earnings 160,462       116,067   116,067 46,535 162,602            
Other comprehensive income (loss), net 20,496         20,474 20,474 22 20,496            
Noncontrolling interest adjustments               (677) (677)            
Joint venture partner distribution declared               (28,027) (28,027)            
Acquisition of minority interest               394 394            
Restricted stock awards (net of cancellations) (in shares)     298                        
Restricted stock awards (net of cancellations)       5,520     5,520   5,520            
Unamortized restricted stock       (10,734)     (10,734)   (10,734)            
Restricted stock amortization       19,826     19,826   19,826            
Tax deficiency from restricted stock awards $ (2,339)     (2,339)     (2,339)   (2,339)            
Dividends         (25,142)   (25,142)   (25,142)            
2024 Convertible Senior Notes - equity component, net of tax                   $ 20,818 $ 20,818 $ 20,818 $ (671) $ (671) $ (671)
Ending Balance (in shares) at Aug. 31, 2017 28,503   28,503                        
Ending Balance at Aug. 31, 2017 $ 1,178,893     $ 315,306 $ 709,103 $ (6,279) $ 1,018,130 $ 160,763 $ 1,178,893